Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Small study tests All-in-One program for diabetes control

NCT ID NCT07186686

Disease control Sponsor: Universidad de Sonora Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a program called AMENUCED for adults with type 2 diabetes in Mexico. The program combines medical care, nutrition advice, and education to help manage the disease. Only 5 people took part to see if they would accept and stick with the program. The goal was to check if this approach is practical, not to prove it works long-term.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
AMENUCED program (medical care, nutritional counseling, behavioral change sessions, and diabetes education)
What this could lead to
If successful, this program could offer a practical, comprehensive approach to help people with type 2 diabetes in Mexico better manage their condition.
What could go wrong
This is a very small pilot study with only 5 participants, so results may not apply to everyone. It only tests feasibility, not long-term effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

5 people

The number who actually took part.

Started

Sep 2025

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged ≥18 and ≤65 years * Residing in Hermosillo, Sonora * Body Mass Index (BMI) ≥25 * Prior diagnosis of Type 2 Diabetes * Individuals who cannot read or write may be included if accompanied by someone willing to attend sessions and assist with comprehension * Must have active medical insurance Exclusion Criteria: * Diabetes-related complications, including: * Advanced diabetic nephropathy * Neuropathy * Retinopathy * Cardiovascular or cerebrovascular diseases * History of severe hypoglycemia * Significant metabolic dysregulation (HbA1c ≥10%) * Use of insulin, sulfonylureas, or meglitinides * Pregnancy or breastfeeding within the past 6 months * Diagnosed psychiatric disorders * Consumption of ≥14 alcoholic beverages per week * Serious illnesses (e.g., cancer, liver failure, kidney disease) * Chronic use of corticosteroids * Plans to relocate during the study period * Weight loss greater than 5% in the past three months * History of bariatric surgery * Any other medical, psychiatric, or behavioral condition that, in the investigator's judgment, may interfere with participation in the intervention

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabete type 2 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabete type 2

Contacts and locations

Locations

  • Centro de Promoción de Salud Nutricional (CPSN), Hermosillo, Sonora 83000

    Hermosillo, Sonora, 83000, Mexico

More trials for these conditions

Other studies related to the condition(s) this trial covers.